Fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy is highly effective treatment for relapsed patients with CLL
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Fludarabine, cyclophosphamide, and rituximab chemoimmunotherapy is highly effective treatment for relapsed patients with CLL
Authors
Keywords
-
Journal
BLOOD
Volume 117, Issue 11, Pages 3016-3024
Publisher
American Society of Hematology
Online
2011-01-19
DOI
10.1182/blood-2010-08-304683
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Rituximab Plus Fludarabine and Cyclophosphamide Prolongs Progression-Free Survival Compared With Fludarabine and Cyclophosphamide Alone in Previously Treated Chronic Lymphocytic Leukemia
- (2010) Tadeusz Robak et al. JOURNAL OF CLINICAL ONCOLOGY
- Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial
- (2010) M Hallek et al. LANCET
- Does reduced-intensity allogeneic transplantation confer a survival advantage to patients with poor prognosis chronic lymphocytic leukaemia? A case-control retrospective analysis
- (2009) J. Delgado et al. ANNALS OF ONCOLOGY
- Emerging therapies for patients with advanced chronic lymphocytic leukaemia
- (2009) Julio Delgado et al. BLOOD REVIEWS
- Treatment of fludarabine-refractory chronic lymphocytic leukemia
- (2009) Apostolia-Maria Tsimberidou et al. CANCER
- The role of stem cell transplantation in the management of chronic lymphocytic leukaemia
- (2009) Constantine S. Tam et al. HEMATOLOGICAL ONCOLOGY
- Standardized MRD flow and ASO IGH RQ-PCR for MRD quantification in CLL patients after rituximab-containing immunochemotherapy: a comparative analysis
- (2009) S Böttcher et al. LEUKEMIA
- Treatment of elderly patients with chronic lymphocytic leukemia
- (2009) Barbara Eichhorst et al. LEUKEMIA & LYMPHOMA
- Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia
- (2008) L. Z. Rassenti et al. BLOOD
- Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia
- (2008) C. S. Tam et al. BLOOD
- Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines
- (2008) M. Hallek et al. BLOOD
- Sequential Therapy With Fludarabine, High-Dose Cyclophosphamide, and Rituximab in Previously Untreated Patients With Chronic Lymphocytic Leukemia Produces High-Quality Responses: Molecular Remissions Predict for Durable Complete Responses
- (2008) Nicole Lamanna et al. JOURNAL OF CLINICAL ONCOLOGY
- Chemoimmunotherapy With Low-Dose Fludarabine and Cyclophosphamide and High Dose Rituximab in Previously Untreated Patients With Chronic Lymphocytic Leukemia
- (2008) Kenneth A. Foon et al. JOURNAL OF CLINICAL ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started